ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (1): 1-7.DOI: 10.3969/j.issn.1006⁃298X.2026.01.001

• 论著 •    下一篇

成人发病肾单位肾痨患者临床表型与基因型分析

  

  • 出版日期:2026-02-27 发布日期:2026-02-27

Genotype and phenotype analysis of patients with adult⁃onset nephronophthisis

  • Online:2026-02-27 Published:2026-02-27

摘要: 目的:探讨成人肾单位肾痨 (NPHP) 患者基因型与临床表型特征。方法:收集 2016 年 1 月至 2025 年 9 月就诊于国家肾脏疾病临床医学研究中心且于成人后发病的 NPHP 患者,分析其临床病理特征、基因检测结果及预后。结果:共纳入 29 例患者,其中 18 例男性、11 例女性,中位发病年龄为 24 (19,34) 岁。多数患者因体检发现血清肌酐升高或出现尿毒症相关症状就诊。就诊时的中位估算的肾小球滤过率 (eGFR) 为 31 (15,53) mL/(min・1.73 m²),中位蛋白尿水平为 0.43 (0.22,0.66) g/24h,合并贫血和高血压的比例分别为 62% 和 38%,58% 的患者出现肾囊肿改变。11 例患者行肾活检,表现为不同程度的肾小管间质慢性病变。基因检测共检出 6 种致病基因:NPHP1 突变 21 例、NPHP3 突变 2 例、NPHP4 突变 3 例、NPHP6 (CEP290) 1 例、NPHP14 (ZNF423) 1 例和 NPHP16 (ANKS6) 1 例突变。22 例 (76%) 患者表现为孤立性肾脏受累,7 例 (24%) 患者出现了系统性受累的表现 (3 例中枢神经系统异常、3 例眼部受累及 1 例骨骼发育异常), 其中 6 例为 NPHP1 突变、1 例为 NPHP6 (CEP290) 突变。随访过程中 17 例 (59%) 患者进展至终末期肾病 (ESKD), 其进展至 ESKD 的中位年龄为 22 (19,40) 岁。其中 NPHP1 全外显子纯合缺失的患者进展至 ESKD 的速度显著快于其他突变形式的患者。结论:NPHP 是一种以肾小管间质病变为主要临床表现的遗传性肾病,成人患者起病隐匿,尿检异常程度较轻而早期出现肾功能损害,部分患者合并系统性受累的表现。NPHP1 是最常见的致病基因,其中 NPHP1 全外显子纯合缺失预示更严重的疾病结局。

关键词: 肾单位肾痨, 成人发病, 囊性肾脏病, 基因型, 表型

Abstract: Objective:To investigate genotypic and phenotypic characteristics of adult⁃onset nephronophthisis (NPHP) patients. Methods:We retrospectively reviewed medical records of adult⁃onset NPHP patients treated at the National Clinical Research Center for Kidney Diseases between January 2016 and September 2025. Clinicopathological features, genetic results, and prognosis were analyzed. Results:29 patients were included (18 males,11 females),with median onset age of 24 (19,34) years. Most presented with elevated serum creatinine on routine testing or uremic symptoms. Median eGFR at diagnosis was 31 (15,53) ml/(min·1.73 m²); median proteinuria was 0.43 (0.22,0.66) g/24h. Anemia and hypertension prevalences were 62% and 38%,respectively. Renal cysts were present in 58%. Among 11 patients biopsied,all showed chronic tubulointerstitial damage. Genetic testing identified 6 pathogenic genes:NPHP1 (21 cases),NPHP3(2),NPHP4(3),and one case each of NPHP6(CEP290),NPHP14(ZNF423),and NPHP16(ANKS6). Isolated kidney disease occurred in 22 patients (76%);7(24%) had systemic involvement (3 central nervous system,3 ocular,1 skeletal). Of these,6 carried NPHP1 mutations and 1 carried an NPHP6 mutation. During follow⁃up,17 patients (59%) progressed to ESKD at median age 22 (19,40) years. Homozygous whole⁃exon deletion of NPHP1 led to significantly faster progression to ESKD versus other mutations. Conclusion:NPHP is a hereditary tubulointerstitial kidney disease. Adult⁃onset NPHP is characterized by an insidious onset and mild urinary abnormalities,but typically presents with early renal impairment. Some patients show systemic involvement. NPHP1 is the most common pathogenic gene,with homozygous whole⁃exon deletion predicting worse outcomes.

Key words: nephronophthisis, adult?onset, renal cystic disease, phenotype, genotype